Muscular Disorder TRIZ Cases
- Bazedoxifene Muscle Cell Protection Through Membrane Resistance
This case replaces complex gene therapy with bazedoxifene to improve muscle membrane resistance and survival.
- Myogenic Progenitor Cell Engraftment via Calcium Modulation
Calcium-modulating agents increase intracellular Ca2+ levels in myogenic progenitor cells to enhance muscle stem cell integration.
- Engineered Myotropic Extracellular Vesicles for Muscle-Targeted Drug Delivery
Myotropic extracellular vesicles display surface targeting moieties to achieve precise muscle delivery, resolving off-target toxicity and immunogenicity issues.
- In Vitro Skeletal Muscle Tissue Culturing via Cyclic Stretching
Culturing skeletal muscle tissue by cyclically stretching precursor cells resolves host graft feasibility issues while enhancing tissue density.
- saRNA Modulators Upregulating Utrophin Expression
Small activating RNA molecules target the utrophin gene promoter to increase protein levels, compensating for dystrophin deficiency in muscular dystrophy.
- Thrombospondin-1 Inhibitors for Aged Muscle Regeneration
Blocking the thrombospondin-1 and CD47 interaction on muscle stem cells reverses age-related atrophy by restoring proliferation rates.
- Biodegradable Thermally Responsive Hydrogel for Cardiac Tissue Repair
Biodegradable elastomeric copolymers solidify at body temperature to support damaged cardiac tissue.
- Ponciri Fructus Extract for Muscle Disease Treatment
Ponciri Fructus extract addresses limited pharmaceutical options by increasing myotube differentiation gene expression to improve muscle weight.
- 3D Co-Culture of Pluripotent Stem Cells for Muscle Stem Cell Expansion
Co-culturing pluripotent stem cells with fibroblasts and endothelial cells in 3D spheroids maintains uncommitted muscle stem cell populations.